Indication

Target/marker/pathway

Summary

Licensing status

Publication and contact information

Autoimmune disease

Rheumatoid arthritis (RA)

Endoplasmic reticulum to nucleus signaling 1 (ERN1; IRE1)

In vitro and mouse studies suggest inhibiting IRE1 could help treat RA. Macrophages from the synovial fluid of patients with RA showed lower IRE1 activation than macrophages from patients with osteoarthritis (OA). In a mouse model of inflammatory arthritis, myeloid-specific Ire1 knockout or an Ire1-specific inhibitor protected from the disease and decreased joint inflammation compared with no knockout or with vehicle. Next steps include testing IRE1 inhibitors in large animal models of RA.
MannKind Corp.'s IRE1 inhibitor MKC204 is in preclinical testing to treat multiple myeloma (MM).

SciBX 6(36); doi:10.1038/scibx.2013.987
Published online Sept. 19, 2013

Findings unpatented; unavailable for licensing

Qiu, Q. et al. EMBO J.; published online Aug. 13, 2013;
doi:10.1038/emboj.2013.183
Contact: Deyu Fang, Northwestern University, Chicago, Ill.
e-mail:

fangd@northwestern.edu
Contact: Kezhong Zhang, Wayne State University School of Medicine,
Detroit, Mich.
e-mail:

kzhang@med.wayne.edu